FDA [to 6 January 2018]
January 03, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to facilitate efficient generic drug review to enhance competition, promote access and lower drug prices
Fondation Merieux  [to 6 January 2018]
December 14, 2017
Exploring the Lesser-known Benefits of Vaccination at the Meeting: ”Communication of Vaccine Benefit beyond the Infection Prevented”
Les Pensières Center for Global Health, Veyrier-du-Lac (France)
44 experts from 12 countries participated in the conference on “Communication of vaccine benefit beyond the infection prevented”, which was organized by the Mérieux Foundation at Les Pensières Center for Global Health, December 4-6.

Gavi [to 6 January 2018]
04 January 2018
Gavi welcomes new UNICEF executive director
Former USAID Administrator Henrietta Fore replaces Tony Lake as UNICEF chief.
GHIT Fund   [to 6 January 2018]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical ·
2017.12.22      Events
Event Report: GHIT R&D Forum
GHIT held its inaugural R&D Forum on December 8, 2017. 130 domestic and international researchers participated, joining discussions on GHIT invested projects ranging from target research to clinical trials. In addition, GHIT executives, along with representatives from the Japan Agency for Medical Development (AMED), EDCTP, and UNITAID, discussed co-funding partnerships.
Speakers from GHIT’s product development partner organizations shared lessons learned and explored related R&D challenges and opportunities through interactive sessions with the broader participant group.
Productive questions and answer sessions following each panel covered such topics as how to find appropriate partners, the ingredients of successful cross-border R&D partnerships, issues pertaining to the conduct of clinical trials in low- and middle-income countries, and aligning strategies between funders.
Speaker information and presentations are available here.

Global Fund [to 6 January 2018];&country=
Stop TB and Global Fund Deepen Cooperation to Find Missing Cases of TB
18 December 2017
The Stop TB Partnership and the Global Fund today signed a new collaboration agreement to contribute towards the goal of finding and treating an additional 1.5 million people with tuberculosis who are currently missed by health systems.
Under the TB Strategic Initiative, the Stop TB Partnership will work with national TB programs and partners in 13 countries, providing technical support through a combination of innovative approaches and best practices to remove barriers to accessing TB services, with a particular focus on key populations and vulnerable groups…

IVAC  [to 6 January 2018]
New – Pneumonia And Diarrhea Progress Report Appendix Available
IVAC-PHU Vaccine Podcast Series: Kate O’Brien on Vaccines and Social Justice
MSF/Médecins Sans Frontières  [to 6 January 2018]
Press release
Health Surveys Reveal Need for Increased Aid in Southern Syria
AMMAN, JORDAN, DECEMBER 20, 2017—Humanitarian assistance for people living in southern Syria needs to increase significantly, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today, as it released two reports on the health of people in the war-torn area of eastern Daraa.

Press release
MSF Challenges Gilead’s Hepatitis C Patent Application in China
December 18, 2017
The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a patent challenge in China to block Gilead’s patent application for the combination of two key oral hepatitis C medicines, sofosbuvir and velpatasvir.
NIH  [to 6 January 2018]
December 22, 2017
Zika remains a research and public health challenge, say NIAID scientists
— The virus has become established in more than 80 countries, infected millions of people, and left many babies with birth defects.
PATH  [to 6 January 2018]
Announcement | December 27, 2017
PATH welcomes WHO’s prequalification of a new bivalent oral polio vaccine from China
Another affordable vaccine against polio will help close the supply gap and improve accessibility for low-income countries
PATH welcomes the World Health Organization’s (WHO) prequalification of a new bivalent oral polio vaccine (bOPV) developed by Chinese vaccine manufacturer Beijing Bio-Institute Biological Products (BBIBP). The vaccine will help meet heightened demand for bOPV during this current critical phase of polio eradication in polio-endemic countries and other countries at high risk for resurgence.
PATH provided technical assistance to BBIBP in the key early stages of the WHO prequalification application process, including document preparation for the Product Summary File. PATH also designed and conducted a Phase 3 clinical trial in Kenya to demonstrate the vaccine’s performance in a setting outside of China and where it is likely to be used most…

Sabin Vaccine Institute  [to 6 January 2018]
January 3, 2018
First typhoid conjugate vaccine achieves WHO prequalification, a key step in protecting children and reducing the burden of typhoid
Geneva, Switzerland –– A typhoid conjugate vaccine has been prequalified by the World Health Organization (WHO), bringing the vaccine one step closer to reaching millions more people at risk of typhoid.

UNAIDS [to 6 January 2018]
19 December 2017
Imams and faith leaders embrace HIV awareness in Côte d’Ivoire

UNICEF  [to 6 January 2018]
1 January 2018
Henrietta Fore becomes new UNICEF Executive Director
NEW YORK, 1 January 2018 – Henrietta Fore takes office today as UNICEF’s seventh Executive Director.  Ms. Fore brings to the role more than four decades of private and public sector leadership experience.
[See Milestones above for more detail]

UNICEF airlifts nearly 6 million doses of vaccines for children in Yemen amid intensifying violence and import restrictions
SANA’A, 20 December 2017 – A UNICEF-chartered plane landed today in Sana’a and delivered nearly 6 million doses of essential vaccines to protect millions of children at risk of preventable diseases, including the current diphtheria outbreak that has reportedly infected over 300 people and killed 35. Most diphtheria cases and deaths are among children.
[See Milestones above for more detail]